FAF
MD icon

Fjarde Ap-fonden’s Pediatrix Medical MD Stock Holding History

Fjarde Ap-fonden’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2
Closed – – 630
2017
Q4 		$0 Sell
2
-31,055
-100% -$1.47M ﹤0.01% 639
2017
Q3 		$1.34M Buy
31,057
+3,057
+11% +$145K 0.03% 585
2017
Q2 		$1.69M Buy
28,000
+3,773
+16% +$224K 0.03% 558
2017
Q1 		$1.68M Sell
24,227
-1,810
-7% -$126K 0.04% 531
2016
Q4 		$1.74M Sell
26,037
-1,726
-6% -$112K 0.04% 524
2016
Q3 		$1.84M Sell
27,763
-462
-2% -$31.6K 0.04% 514
2016
Q2 		$2.04M Sell
28,225
-516
-2% -$35.5K 0.05% 467
2016
Q1 		$1.86M Buy
28,741
+3,010
+12% +$200K 0.04% 501
2015
Q4 		$1.84M Buy
+25,731
New +$1.9M 0.05% 465

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fjarde Ap-fonden's MD Position: Q1 2018 in Review

Fjarde Ap-fonden sold out of Pediatrix Medical (MD) in Q1 2018, closing a stake of 2 shares.

Fjarde Ap-fonden first reported a position in MD in Q4 2015 and held it in 9 quarters. The position peaked at $2.04M in Q2 2016. 342 funds tracked by Wall St. Rank hold MD as of Q1 2018.

  • Fjarde Ap-fonden reported no remaining Pediatrix Medical position as of Q1 2018 after selling out during the quarter.
  • Fjarde Ap-fonden sold 2 Pediatrix Medical shares in Q1 2018.
  • Fjarde Ap-fonden first reported a position in Pediatrix Medical in Q4 2015 and held it in 9 quarters.
  • Fjarde Ap-fonden's Pediatrix Medical position peaked at $2.04M in Q2 2016.
  • 342 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2018.

Based on Fjarde Ap-fonden's 13F filing for Q1 2018, filed 7 May 2018.